| Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome TE Long, D Helgason, S Helgadottir, R Palsson, T Gudbjartsson, ... Anesthesia & analgesia 122 (6), 1912-1920, 2016 | 119 | 2016 |
| Association between preoperative opioid and benzodiazepine prescription patterns and mortality after noncardiac surgery MI Sigurdsson, S Helgadottir, TE Long, D Helgason, NH Waldron, ... JAMA surgery 154 (8), e191652-e191652, 2019 | 42 | 2019 |
| Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: results of the iStopMM study TE Long, OS Indridason, R Palsson, S Rognvaldsson, TJ Love, ... Blood Cancer Journal 12 (9), 133, 2022 | 36 | 2022 |
| Acute kidney injury following coronary angiography: a nationwide study of incidence, risk factors and long-term outcomes D Helgason, TE Long, S Helgadottir, R Palsson, GH Sigurdsson, ... Journal of nephrology 31, 721-730, 2018 | 27 | 2018 |
| Improved long‐term survival and renal recovery after acute kidney injury in hospitalized patients: a 20 year experience TE Long, MI Sigurdsson, GH Sigurdsson, OS Indridason Nephrology 21 (12), 1027-1033, 2016 | 23 | 2016 |
| Postoperative acute kidney injury: focus on renal recovery definitions, kidney disease progression and survival TE Long, S Helgadottir, D Helgason, GH Sigurdsson, T Gudbjartsson, ... American journal of nephrology 49 (3), 175-185, 2019 | 19 | 2019 |
| Epidemiology of acute kidney injury in a tertiary care university hospital according to the RIFLE criteria TE Long, MI Sigurdsson, OS Indridason, K Sigvaldason, GH Sigurdsson Laeknabladid 99 (11), 499-503, 2013 | 12 | 2013 |
| Prevalence of MGUS is high in the istopmm study but the prevalence of IgA MGUS does not increase with age in the way other immunoglobulin subtypes do TJ Love, S Rögnvaldsson, S Thorsteinsdottir, T Aspelund, ER Reed, ... Blood 140 (Supplement 1), 256-258, 2022 | 9 | 2022 |
| Mild Stage 1 post-operative acute kidney injury: association with chronic kidney disease and long-term survival TE Long, D Helgason, S Helgadottir, GH Sigurdsson, R Palsson, ... Clinical Kidney Journal 14 (1), 237-244, 2021 | 8 | 2021 |
| Long‐term survival after intensive care: A retrospective cohort study EA Kristinsdottir, TE Long, K Sigvaldason, S Karason, GH Sigurdsson, ... Acta Anaesthesiologica Scandinavica 64 (1), 75-84, 2020 | 6 | 2020 |
| Validity of chronic disease diagnoses in Icelandic healthcare registries S Rögnvaldsson, TE Long, S Thorsteinsdottir, TJ Love, SY Kristinsson Scandinavian Journal of Public Health 51 (2), 173-178, 2023 | 4 | 2023 |
| Autoimmune diseases are not associated with monoclonal gammopathy of undetermined significance: results of the prospective population-based Istopmm study IS Sverrisdottir, S Thorsteinsdóttir, S Rögnvaldsson, T Aspelund, ... Blood 140 (Supplement 1), 10031-10032, 2022 | 4 | 2022 |
| Defining new reference intervals for serum free light chains in individuals with reduced kidney function: results of the population-based on iceland screens treats or prevents … T Einarsson Long, OS Indridason, R Palsson, S Rögnvaldsson, TJ Love, ... Blood 138 (Supplement 1), 542-542, 2021 | 4 | 2021 |
| Predicting the need for upfront bone marrow sampling in individuals with MGUS: derivation of a multivariable prediction model using the prospective population-based Istopmm cohort E Eythorsson, S Rögnvaldsson, S Thorsteinsdóttir, ER Reed, ... Blood 140 (Supplement 1), 266-267, 2022 | 3 | 2022 |
| Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study TE Long, S Rögnvaldsson, S Thorsteinsdottir, I Sverrisdottir, E Eythorsson, ... Blood 142, 535, 2023 | 2 | 2023 |
| Monoclonal gammopathy of undetermined significance and risk of chronic kidney disease: results of the population-based Iceland screens, treats, or prevents multiple myeloma … T Einarsson Long, E Eythorsson, S Rögnvaldsson, O Indridason, ... Blood 140 (Supplement 1), 10108-10109, 2022 | 1 | 2022 |
| Transient M-proteins: epidemiology, causes, and the impact of mass spectrometry: the Istopmm study R Palmason, O Berlanga, JK Sigurdsson, S Rögnvaldsson, ... Blood 140 (Supplement 1), 2338-2340, 2022 | 1 | 2022 |
| Áhrif skertrar nýrnastarfsemi á snemmkominn árangur kransæðahjáveituaðgerða N Sveinsdottir, SR Heidarsdottir, AS Steinthorsson, H Jóhannesdóttir, ... | 1 | 2022 |
| Bráður nýrnaskaði á Landspítala 2008-2011 og áhættuþættir og afdrif sjúklinga með alvarlegan skaða ÞE Long, MI Sigurðsson, ÓS Indriðason, K Sigvaldason, GH Sigurðsson Læknablaðið, 2013 | 1 | 2013 |
| Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance: A Cohort Study Nested in a … E Eythorsson, S Rognvaldsson, S Thorsteinsdottir, T Einarsson Long, ... Annals of Internal Medicine, 2024 | | 2024 |
Martin Ingi SigurdssonLandspitali University HospitalVerified email at landspitali.is
